Pharmaceuticals

Male Infertility Market Insights Highlighting Opportunities Supporting Growth To 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Male Infertility Market Between 2026 And 2030?

The male infertility market size has seen substantial growth recently. It is set to expand from $4.33 billion in 2025 to $4.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.6%. This historical expansion can be attributed to a global decline in sperm quality, the heightened prevalence of lifestyle-related infertility, the proliferation of fertility clinics, increasing acceptance of ART procedures, and advancements in semen analysis techniques.

The male infertility market size is projected to experience substantial expansion over the upcoming years. This market is projected to reach $5.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth is driven by several factors, including an increase in infertility rates linked to environmental elements, a heightened demand for IVF and ICSI procedures, innovations in fertility diagnostics, a growing understanding of male reproductive health, and wider availability of fertility treatments in developing regions. Key trends during this period encompass the increasing embrace of assisted reproductive technologies, a greater reliance on sophisticated sperm diagnostic tests, an escalating emphasis on hormonal and targeted drug therapies, the broadening of microsurgical interventions for male infertility, and enhanced recognition leading to earlier diagnosis of male infertility.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

Which Key Drivers Are Affecting The Male Infertility Market Development?

Elevated stress levels are projected to drive the expansion of the male infertility market in the future. Stress levels refer to the degree of emotional, physical, or mental strain encountered in demanding situations or pressures. The rise in stress levels primarily stems from escalating work demands, where constant pressure and high expectations lead to burnout, disrupting mental well-being and work-life balance. Heightened stress can interfere with hormone balance, reduce sperm quality, and impair sexual function, contributing to male infertility. Chronic stress disrupts cortisol and testosterone levels, leading to an increase in infertility cases. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization of psychologists, 43% of adults in the US reported feeling more anxious in 2024, compared to 37% in 2023 and 32% in 2022, indicating a consistent upward trend in anxiety levels. Thus, increasing stress levels are a key driver for the growth of the male infertility market.

How Is The Male Infertility Market Broken Down By Segment Categories?

The male infertility market covered in this report is segmented –

1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology

2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types

3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies

4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users

Subsegments:

1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists

2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures

3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm

What Trends Are Transforming The Male Infertility Market?

Leading companies within the male infertility market are prioritizing strategic partnership approaches to broaden the availability of cutting-edge fertility treatments across worldwide markets. Such partnerships represent collaborative efforts between entities, combining their respective resources and specialized knowledge to accomplish mutual objectives, thereby stimulating innovation, extending market presence, and strengthening research and development activities. As an illustration, in June 2024, Ferring Pharmaceuticals, a pharmaceutical company based in Switzerland, formed a partnership with Posterity Health, a US-based male fertility clinic, to introduce a male fertility program on Ferring’s Fertility Out Loud platform designed to inform men about their fertility. This initiative provides a confidential online assessment and educational materials crafted by reproductive urologists to help men gain insight into their fertility status and diminish the societal stigma associated with male infertility, which contributes to as much as 50% of all infertility cases. The program endeavors to enable men to act proactively, potentially enhancing a couple’s journey to parenthood by addressing male fertility concerns earlier and more conveniently through digital tools and telehealth services.

Which Players Are Present In The Male Infertility Market Space?

Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics

Get The Full Male Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

Which Region Accounts For The Largest Portion Of The Male Infertility Market?

North America was the largest region in the male infertility market in 2025. The regions covered in the male infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Male Infertility Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

Browse Through More Reports Similar to the Global Male Infertility Market 2026, By The Business Research Company

Male Fertility Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report

Infertility Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Fertility Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795